AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 65(4), 2001, pp. 346-350
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaffel, R
Right arrow Articles by Pulcheri, W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaffel, R
Right arrow Articles by Pulcheri, W
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Strongyloidiasis
Right arrow Travel Medicine
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 4, 346-350
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies

R Schaffel, M Nucci, E Carvalho, M Braga, L Almeida, R Portugal, and W Pulcheri

The diagnosis of strongyloidiasis relies upon the identification of the parasite in stool samples. In 1981, a serologic assay was developed, which was useful in the diagnosis of strongyloidiasis in the immunocompetent host. In the present study, we evaluated the enzyme-linked immunosorbent assay (ELISA) in patients with hematologic malignancies. Between April 1995 and December 1998, sera from 164 consecutive patients were tested for the presence of IgG antibody to Strongyloides stercoralis. Patient was considered uninfected after at least three negative stool examinations. The prevalence of strongyloidiasis was 13%. The underlying diseases were acute leukemia in 21% and lymphoma in 52% of the patients. The majority of the patients were receiving chemotherapy (93%) and steroids (76%). The sensitivity, specificity, and positive and negative predictive values were 68%, 89%, 48%, and 95%, respectively. The ELISA may be an excellent assay to rule out the diagnosis of strongyloidiasis in patients with hematologic malignancies.


This article has been cited by other articles:


Home page
 JAMAHome page
K. R. Page and J. Zenilman
Eosinophilia in a Patient From South America
JAMA, January 30, 2008; 299(4): 437 - 444.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
H. R. van Doorn, R. Koelewijn, H. Hofwegen, H. Gilis, J. C. F. M. Wetsteyn, P. J. Wismans, C. Sarfati, T. Vervoort, and T. van Gool
Use of Enzyme-Linked Immunosorbent Assay and Dipstick Assay for Detection of Strongyloides stercoralis Infection in Humans
J. Clin. Microbiol., February 1, 2007; 45(2): 438 - 442.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
P. P. YORI, M. KOSEK, R. H. GILMAN, J. CORDOVA, C. BERN, C. B. CHAVEZ, M. P. OLORTEGUI, C. MONTALVAN, G. M. SANCHEZ, B. WORTHEN, et al.
SEROEPIDEMIOLOGY OF STRONGYLOIDIASIS IN THE PERUVIAN AMAZON
Am J Trop Med Hyg, January 1, 2006; 74(1): 97 - 102.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
P. B. Keiser and T. B. Nutman
Strongyloides stercoralis in the Immunocompromised Population
Clin. Microbiol. Rev., January 1, 2004; 17(1): 208 - 217.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.